Canadian pharmacy chain Consumers Drug Mart has partnered with blockchain firm TruTrace Applied sciences Inc. to launch a pilot program for monitoring the hashish provide chain by way of blockchain, in accordance with a Bloomberg report on June 17.
Based on the report, this blockchain monitoring system will likely be used to determine and observe medical hashish, with information included such because the supply and genetics of the pressure. This information will presumably enable docs to difficulty simpler prescriptions, in addition to present strong info for medical trials of medical marijuana.
Consumers Drug Mart govt Ken Weisbrod commented on how this new stage of specificity will help, saying:
“They’ll say, 'This explicit product, pressure, cultivar has this chemical element and my affected person remains to be on this drug and has achieved nice outcomes. […] Then we are able to begin triangulating that information. It is a huge leap for the trade.”
The motivation behind the monitoring system is to calm the issues of sufferers and docs, by “mak[ing] it's extra like conventional medication,” says Weisbrod.
Commenting on TruTrace's motivations, the corporate's CEO, Robert Galarza, stated he hopes the corporate's current partnership with Consumers Drug Mart might be leveraged into related offers with US drugstore chains CVS and Walgreens, which already promote hashish merchandise.
As beforehand reported by Cointelegraph, Colorado-based Web of Issues safety firm CyberCar partnered with provide chain software program firm Webjoint in 2017 to make use of an automotive-based monitoring system on blockchain for hashish shipments.
Based on the report, the blockchain system will observe drivers and autos mechanically. Webjoint CEO Chris Dell'Olio commented on how CyberCar's driver monitoring would assist his enterprise, saying:
“Compliance reporting has at all times been the most important hurdle for the hashish trade. With CyberCar built-in into our resolution, we’re capable of absolutely automate all municipal and state reporting necessities.”
